|
How to Advertise on Betterchem.com…
Most advertising on this site is managed by Google Adwords. Adwords lets businesses advertise on sites
regardless of their budget. At Betterchem, your Ad campaigns can target keywords and/or the visitor's
geographical location. We do not participate in Adwords targeted campaigns at this time.
|
|
|
|
|
If you would like to target one or more of our network's 200,000 plus pages…
Purchase a banner space for a low monthly fee. Banner spaces on individual pages are available for as little as $50/month. Email sales@betterchem.com. Place "Banner Placement" in the subject line and include our page's URL (where you'd like your banner to appear) in the subject. You need to supply us with links to your banner image and URL for the target page (at your site). We will revert with price and conditions. Betterchem reserves the right to refuse ads that do not meet our editorial standards.
|
|
Free
Ad space for your pharma products.
Simply list your products and create a reciprocal link. See how.
|
| Keywords for the Ads: Advair Diskus (fluticasone propionate/salmeterol) Inhalation Powder, GlaxoSmithKline NDA 21-077/S19 8/11/03 8/15/03 8/15/03
Advair Diskus (fluticasone propionate/salmeterol) Inhalation Powder, GlaxoSmithKline NDA 21-077/S8 8/21/02 8/26/02
Advair Diskus,100/50, 250/50 and 500/50, Glaxo Wellcome. NDA 21-077 Cutivate (fluticasone propionate) Cream, 0.05%, GlaxoSmithKline NDA 19-958/S13 4/16/02 4/22/02 4/18/02
Cutivate (fluticasone propionate cream) Cream, 0.005%, Glaxo Wellcome NDA 19-958-SE5-008 6/17/99 6/22/99 6/22/99 7/3/00
Cutivate Indication: A medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. (This supplement provides for use in pediatric patients ages 3 months and older.) Cutivate (fluticasone propionate) Ointment, 0.005%, GlaxoSmithKline NDA 19-957/S11 1/18/02 2/5/02 2/5/02
Cutivate (fluticasone propionate) Ointment GlaxoSmithKline NDA 19-957/S7 & S/9 Flonase Nasal Spray, 50 mcg, GlaxoSmithKline NDA 20-121/S28 5/1/03 7/9/03
Flonase Nasal Spray, 50 mcg, GlaxoSmithKline, NDA 20-121/S23 5/23/02 6/3/02
Flonase (fluticasone propionate) Nasal Spray, GlaxoSmithKline, NDA 20-121/S11, S13, & S20 5/9/02 5/21/02
Flonase (fluticasone propionate) Nasal Spray, 50 mcg, GlaxoWellcome NDA 20-121/S-009 12/11/98 12/14/98 9/14/01
Flonase Indication: For perennial nonallergic rhinitis for ages 4 and above. Flovent (fluticasone propionate) Inhalation Aerosol, GlaxoSmithKline NDA 20548/S19 10/8/03 10/16/03 10/16/03
Flovent (fluticasone propionate) Inhalation Aerosol, GlaxoSmithKline NDA 20548/S015/16 6/20/03 7/6/03 7/8/03
Flovent (fluticasone propionate inhalation powder) Rotadisk, GlaxoSmithKline NDA 20548/S14 10/8/03
Flovent (fluticasone propionate inhalation powder) Rotadisk Glaxo Wellcome NDA 20548/S008 & 20-549/S-002 12/22/98 5/23/01
Flovent (fluticasone propionate inhalation powder) Rotadisk Glaxo Wellcome NDA 20549/S-014 10/8/03 10/16/03 10/16/03 5/23/01
Flovent (Fluticasone Propionate) Inhalation Powder Rotadisk GlaxoSmithKline NDA 20-549/S11/S12 6/20/03 7/6/03 7/8/03
Flovent (fluticasone dipropionate inhalation powder) Rotadisk Glaxo Wellcome NDA 20-549/S-006 7/19/99 5/23/01
Flovent (fluticasone propionate inhalation powder) Rotadisk Glaxo Wellcome NDA 20-549/S-008 3/29/01
Flovent Diskus (fluticasone dipropionate inhalation powder). Glaxo Wellcome NDA 20-833/S-002 11/1/02 11/18/02
Flovent Diskus (fluticasone dipropionate inhalation powder). GlaxoSmithKline NDA 20-833/S-008 11/1/02 11/18/02
Flovent Diskus (fluticasone dipropionate) inhalation powder, 50mcg, 100mcg, 250mcg, GlaxoWellcome NDA 20-833 9/29/00 10/10/00
Indication: This new drug application provides for the use of Flovent Diskus 50 mcg, Flovent Diskus 100 mcg and Flovent Diskus 250 mcg (fluticasone propionate) Inhalation Powder for the maintenance treatment of asthma as prophylactic therapy in adults and pediatric patients 4 years of age and older. It is also indicated for patients requiring oral corticosteroid therapy for asthma. Many of these patients may be able to reduce or eliminate their requirement for oral corticosteroids over time.
Fluticasone Propionate Ointment, 0.005%, Tentatively Approved Altana ANDA 76-300 FLUTICASONE PROPIONATE Aerosol, Metered; Inhalation 0.044MG/INH FLOVENT GlaxoSmithKline 020548 FLUTICASONE PROPIONATE Aerosol, Metered; Inhalation 0.11MG/INH FLOVENT GlaxoSmithKline 020548 FLUTICASONE PROPIONATE Aerosol, Metered; Inhalation 0.22MG/INH FLOVENT GlaxoSmithKline 019958 FLUTICASONE PROPIONATE Cream; Topical 0.05% CUTIVATE GlaxoSmithKline 019957 FLUTICASONE PROPIONATE Ointment; Topical 0.005% CUTIVATE GlaxoSmithKline 020549 FLUTICASONE PROPIONATE Powder; Inhalation 0.044MG/INH FLOVENT GlaxoSmithKline 020833 FLUTICASONE PROPIONATE Powder; Inhalation 0.05MG/INH FLOVENT DISKUS 50 GlaxoSmithKline 020549 FLUTICASONE PROPIONATE Powder; Inhalation 0.088MG/INH FLOVENT GlaxoSmithKline 020833 FLUTICASONE PROPIONATE Powder; Inhalation 0.1MG/INH FLOVENT DISKUS 100 GlaxoSmithKline 020549 FLUTICASONE PROPIONATE Powder; Inhalation 0.22MG/INH FLOVENT GlaxoSmithKline 020833 FLUTICASONE PROPIONATE Powder; Inhalation 0.25MG/INH FLOVENT DISKUS 250 GlaxoSmithKline 020121 FLUTICASONE PROPIONATE Spray, Metered; Nasal 0.05MG/SPRAY FLONASE GlaxoSmithKline 021077 FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE Powder; Inhalation 0.1MG/INH;EQ 0.05MG BASE/INH ADVAIR DISKUS 100/50 GlaxoSmithKline 021077 FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE Powder; Inhalation 0.25MG/INH;EQ 0.05MG BASE/INH ADVAIR DISKUS 250/50 GlaxoSmithKline 021077 FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE Powder; Inhalation 0.5MG/INH;EQ 0.05MG BASE/INH ADVAIR DISKUS 500/50 GlaxoSmithKline
© 2008 Betterchem Corp.
|
|
